-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MJt6WTuEF/JeCR72e4L0USwnOlH6a+Isr7LcwAFVZvCf8sdHPP7YavZZIKp1mdrz eP8tcH/4NTY5ze9qW9FNzA== 0000950109-98-001024.txt : 19980218 0000950109-98-001024.hdr.sgml : 19980218 ACCESSION NUMBER: 0000950109-98-001024 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980217 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DIATIDE INC CENTRAL INDEX KEY: 0001011888 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 043078258 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-46265 FILM NUMBER: 98540439 BUSINESS ADDRESS: STREET 1: 9 DELTA DR CITY: LONDONDERRY STATE: NH ZIP: 03053 BUSINESS PHONE: 6034378970 MAIL ADDRESS: STREET 1: 9 DELTA DR CITY: LONDONDERRY STATE: NH ZIP: 03053 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BONSAL FRANK A JR CENTRAL INDEX KEY: 0001005564 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1119 STREET 2: 1119 ST PAUL STREET CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 4102440115 MAIL ADDRESS: STREET 1: 1119 ST PAUL STREET CITY: BALTIMORE STATE: MD ZIP: 21202 SC 13G/A 1 AMENDMENT NO. 1 TO SCHEDULE 13-G --------------------------- OMB APPROVAL --------------------------- OMB number: 3235-0145 Expires: October 31, 1994 Estimated average burden hours per response... 14.90 --------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1 )* Diatide, Inc. ------------------------------------------------------------- (Name of Issuer) Common Stock, $.001 par value --------------------------------------------------- (Title of Class of Securities) 252842109 ----------------------------------------- (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Item 1(a). Name of Issuer: Diatide, Inc. -------------- Item 1(b). Address of Issuer's Principal Executive Offices: ----------------------------------------------- 9 Delta Drive, Londonderry, NH 03053 Item 2(a). Names of Persons Filing: Frank A. Bonsal, Jr. ----------------------- Item 2(b). Address of Principal Business Office or, if None, Residence: ------------------------------------------------- --------- The address of the principal business office of Mr. Bonsal is New Enterprise Associates, 1119 St. Paul Street, Baltimore, Maryland 21202. Item 5. Ownership of Five Percent or Less of a Class. -------------------------------------------- Mr. Bonsal has ceased to own beneficially more than 5% of the outstanding Common Stock of Diatide, Inc. All other items reported on the Schedule 13G dated as of February 10, 1997 and - ------------------------------------------------------------------------------ filed on behalf of Mr. Bonsal and others with respect to the Common Stock of - ---------------------------------------------------------------------------- Diatide, Inc. remain unchanged. - ------------------------------- Page 2 of 3 Pages SIGNATURE --------- After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: February 10, 1998 * - ------------------------------- Frank A. Bonsal, Jr. *By: /s/ Nancy L. Dorman ----------------------------------- Nancy L. Dorman, in her individual capacity and as Attorney-in-Fact - -------------------------------------------------------------------------------- This Schedule 13G was executed by Nancy L. Dorman pursuant to Powers of Attorney filed with the Securities and Exchange Commission on February 13, 1992 in connection with a Schedule 13G for Advanced Interventional Systems Inc. and on February 13, 1995 in connection with a Schedule 13G for Acuity Imaging, Inc., which Powers of Attorney are incorporated herein by reference. Page 3 of 3 Pages -----END PRIVACY-ENHANCED MESSAGE-----